Schedule 13D ownership disclosure
VOR BIOPHARMA INC
Common Stock, par value $0.0001 per share · CUSIP: 929033108
Event date: 2024-12-26
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- RA Capital Management, L.P.Reported CIK 0001346824
Shares: 39,709,850.00 · Class: 31.9%
- Peter KolchinskyReported CIK 0001384859
Shares: 39,709,850.00 · Class: 31.9%
- Rajeev ShahReported CIK 0001619841
Shares: 39,709,850.00 · Class: 31.9%
- RA Capital Healthcare Fund LPReported CIK 0001315082
Shares: 37,820,713.00 · Class: 30.4%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001415889-24-030245
- Form type
- SCHEDULE 13D/A
- Filer
- RA CAPITAL MANAGEMENT, L.P.
- CIK
- CIK 1346824
- Filed
- Dec 30, 2024
- Reporting period
- Dec 26, 2024
- Description
- Schedule 13D beneficial ownership